A B Supplementary Figure S1 PC3 cells Vehicle 3β-Adiol

Slides:

Advertisements

Similar presentations

Supplemental Figure 1 a % pulldown from input LNCaP/scrambled-siRNA Figure 1 A, ChIP analysis of AR and PHB binding to the PSA promoter in the LNCaP/scrambled-siRNA.

Advertisements

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

Supplementary figure S1 A B C D Figure S1. EGF in combination with LY induces survival and NE differentiation of LNCaP cells. LNCaP cells were cultured.

A prognostic model for lymph node negative breast cancer patients by Integrating proliferation and immune response Supplementary figures.

B C Supplementary Figure 1 Control X0 Control X9  -HBx (mAb)  -HBx (rabbit serum) ABCEFD aa ABCEF X0 X9 (  D) A

Mutational analysis of 35 bladder cancer cell lines using RNA-seq.

Supplemental Table 1 Source and authentication of cell lines.

Tissue homogenate with precipitation Tissue homogenate without precipitation Cy5: PP2A 0.1 U Cy5: PP2A 1U Cy3: PP2A 0.1 U Cy3: PP2A 1U Cy5: PP2A 1U Supplementary.

Supplementary Table S1 Clinical exposure for palbociclib, fulvestrant and chemotherapeutic agents used in this study. Palbociclib (1)*Paclitaxel (2)*Doxorubicin.

MDA-MB h MDA-MB h a MDA-MB h MDA-MB-468 MDA-MB h MDA-MB h MCF-7 48h MCF-7 72h b c ef g h MDA-MB h clomipramine.

教育卡（电子卡）身份信息认证指导（学生）. 身份信息认证渠道教育卡管理中心为学生提供了 “ 教育卡官方网站 ” 和 “ 教育人人通客户端 ” 两种认证渠道。 1 教育人人通客户端 2 ●● 您可以在教育卡网站的 “ 人人通客户端 ” 版块下载江苏教育人人通客户端。

Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Potentially Harmful Effect of a Testosterone Dietary.

SA-β-Gal positivity (%) Days after 6 Gy of IR exposure 3 Morphology SA-  -Gal 015 Supplementary Fig. S1 A B.

CFSE B16-ova Annexin V 7AAD +Th17 TGF-  1 +Th17 IL-1  +Th17 TGF-  1 +Th17 IL-1  No T cells a EL-4 B16-ova EL-4 CFSE gated Supplementary figure 1 CD25.

Figure Molecular Biology of the Cell (© Garland Science 2008)

Figure 14-1 Molecular Biology of the Cell (© Garland Science 2008)

Figure 2. Effects of RUNX1 and PU. 1 siRNAs on CCR3 reporter activity

Progesterone receptor

BM SPL PB Beads & Nucleated HLA-ABC+ Beads & Nucleated HLA-ABC+

A B C D Rao et al., 2012; Supplementary Figure S1 p = 0.03 p = NS

Course 3 Parallel Lines In the figure, line n || line m. Find the measure of the angle . 7 All obtuse angles in the figure are congruent m7 = 144°

47,XX,+mar B 47,XX,+13 47,XX,+mar wcp13 wcp13 wcp13 C 47,XX,+13

B c * a Supplementary Figure 1. NLRP1 knockdown suppresses tumor growth in vivo. (a) 1205Lu tumors with NLRP1 shRNA from Santa Cruz Biotechnology. (b)

PGP9.5 ANTIGEN H & E A B Supplementary Figure 1, Ceyhan et al.

Supplementary Figure 1 A B C siControl siRNF31 siRNF31+siP53 siControl

Supplemental Figure S1 a b

1A 1B Supplementary Figure 1. Parp HT29 C-Parp Gapdh LoVo

A B Figure S1 DU145 PC-3 22Rv1 RWPE-1 BPH1 Relative levels

Supplementary Figure S2

Figure 2S (Supplementary Data)

relative to untreated vector

Supplementary figure1. CK7 CK20 CDX2 DPEP1 Cut off value: 85%

Relative protein levels

VEHICLE TECHNOLOGY AIR CONDITIONING SYSTEMS.

VEHICLE TECHNOLOGY BRAKE SYSTEMS.

Supplementary Figure B. 50.

Supplementary Figure 1 a b c d e 1 2 cGMP levels (pmol/ml) vehicle

Supplementary Information 1

Improvement of insulin sensitivity by treatment of the annexin A1 receptor agonist in HFD mice. Improvement of insulin sensitivity by treatment of the.

mRNA level as % relative to

Roth et al, Supplementary Figure 1

Supplementary Figure S4

Estrogen Receptor Transrepresses Brain Inflammation

Copyright © 2013 Elsevier Inc. All rights reserved.

A B C p= ns 4T1BR5 GFP expression P10 P20 4T1BR5-Fluc-GFP Count

Supplementary Fig S1, Zembutsu H et al.

Supplemental Figure 1 A GENE chr location (hg18) SNP sample ID TLR2

Volume 17, Issue 4, Pages (April 2010)

财务管理案例教学法研究及示例 ——王遐昌 2006/11/10.

USP2a overexpression modifies the microRNA expression profile of prostate cells. USP2a overexpression modifies the microRNA expression profile of prostate.

Supplementary Figure 1 SK-N-SH Vehicle GW9662 Number of cells

Supplementary Figure S1

C A B * * * * HCC1954 HCC1569 Supplementary-Figure S5 Tumor cells sc.

Increased signal intensity and significant enrichment of transcription factor motifs is observed with DSG in cell line models. Increased signal intensity.

MW (kDa) 2 µg 0.5 µg Supplementary Figure S1. SDS-PAGE under reducing condition analysis (Coomassie brilliant blue staining) of.

A B D C E F Supplementary Figure S4. Epping et al. IP: flag input IgG

The Chemical Biology of Human Vitamins

Supplementary Figure 3. Characteristics of cryopreserved NK cells with or without incubation and/or IL-2 stimulation after thawing. The cell number (A),

Greater induction of apoptosis following EGFR TKI treatment correlates with higher basal BIM expression across a panel of EGFR-mutant lung cancers. Greater.

Induction of cell death in prostate cancer cells by SAHA and ZOL

Inter-laboratory cohort Prognostication cohort

Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. Per1 inhibits growth and induces apoptosis in prostate cancer cell lines. LNCaP,

--- 6-months’ therapy months’ therapy Supplementary Figure 1.

W. chinensis extract induces apoptosis in AR-dependent prostate cancer cells. W. chinensis extract induces apoptosis in AR-dependent prostate cancer cells.

Complete Vehicle Systems.

Effects of W. chinensis extract on androgen activity and growth of prostate cancer cells. Effects of W. chinensis extract on androgen activity and growth.

Figure 5-1 Molecular Biology of the Cell (© Garland Science 2008)

Effect of 6-SHO on mouse prostate cancer HMVP2 cells.

Presentation transcript:

A B Supplementary Figure S1 PC3 cells Vehicle 3β-Adiol Annexin V positive cells

Supplementary Figure S2 A B 3β–Adiol ERE-Luciferase Reporter (LNCaP cells)

Supplementary Figure S3

Supplementary Figure S4

Supplementary Figure S5 A B PC3 cells LNCaP cells C PC3 cells

Supplementary Figure S6 chr6:109006104-109006412 ½ ERE AP1 B C

Supplementary Figure S7 A B C D E F G H

Supplementary Figure S8 A B C D E F